Neuvivo Adds Former FDA Chief Counsel Peter Barton Hutt as Advisor – QNT Press Release

PALO ALTO, Calif., June 20, 2022 /PRNewswire/ — Neuvivo, a private late-clinical stage company developing an effective treatment for ALS and other neurodegenerative diseases, today announced it has added Peter Barton Hutt as advisor. Peter is senior counsel in the Washington, DC law firm of Covington & Burling LLP, specializing in Food and Drug Law. From 1971-75 Peter was the Chief Counsel for the FDA where he led the adoption of key regulations including a process to reevaluate the safety and efficacy of all biological products licensed in the last hundred years.

He was responsible for the legislation that became the Drug Listing Act of 1972 and the Medical Device…

Full story available on

Source link

Recommended For You

About the Author: News Center